Johnson & Johnson (NYSE:JNJ) has ended its bid to buy Swiss drug company Actelion Pharmaceuticals Ltd. The pursuit of a deal was announced by the companies last month. Actelion shares have risen in recent weeks on expectations of a takeover. Jean-Paul Clozel, Actelion’s chief executive and founder, was reportedly open to a deal that would […]
Mergers & Acquisitions – The Cerbat Gem
Thursday, January 19, 2017
Johnson & Johnson Ends Bid For Actelion
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment